New CEO and President for Medivir

New CEO and President for Medivir

The board has appointed Ron Long as the new CEO and President for Medivir
as of 1st February 2009.

Ron Long was born in 1947 and was elected to Medivir's Board in 2007. He has a
broad experience from the pharmaceutical and life science industry.

Ron is presently an Executive Director of Sky Medical Ltd, Non Executive
Director of DxS Ltd, the Chairman of Procognia Israel and Managing Director and
owner of Scicona Ltd.

He was formally Chairman of Kudos Pharmaceuticals Ltd, Deputy Chairman of The
Automation Partnership Plc, Senior Independent Director Asterand Plc and Non
Executive Director of Gyros AB and Biacore AB. 

Ron Long joined the main Board of Amersham Plc. in August 1990 as Commercial
Director. He then went on to be appointed Managing Director Life Sciences in
1996 and CEO for Amersham Pharmacia Biotech from 1997 until June 2000 when he
was appointed Vice Chairman of the Group until his retirement from Amersham in
June 2001.

Prior to joining Amersham, Ron worked for 22 years with the Wellcome Foundation
plc holding Divisional Director appointments in Wellcome Biotechnology Ltd,
Coopers Animal Health Ltd and was Group Managing Director of Calmic
International Ltd immediately before joining the Main Board at Amersham in 1990.


“Ron's industrial experience will be of great importance for future development
of Medivirs pharmaceutical business” says Anders Vedin, Chairman of the Board.

For further information please contact
Anders Vedin, Chairman of the Board, Medivir AB + 46 708 761570 
(Rein Piir, CFO & VP Investor Relations, Medivir +46 8 5468 3123 or +46 708 537
292)

For more on Medivir, please see the company website: www.medivir.se